Last reviewed · How we verify
NCT03788577
Impact of Oligonol to Cardiometabolic Risk and Muscular Health
NA trial testing Oligonol intake in Muscle Loss in 120 participants. Completed in 1 April 2020.
1 April 2020
Quick facts
| Lead sponsor | National Yang Ming Chiao Tung University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 120 |
| Start date | 4 December 2018 |
| Primary completion | 1 April 2020 |
| Estimated completion | 1 April 2020 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Oligonol intake
- Placebo
Conditions studied
- Muscle Loss — all drugs for Muscle Loss →
- Muscle Weakness — all drugs for Muscle Weakness →
- Quality of Life — all drugs for Quality of Life →
Sponsor
National Yang Ming Chiao Tung University
Who can join
50 and older, any sex, with Muscle Loss or Muscle Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will mainly focus on Middle and old-aged adults, and examine whether Cardiovascular and metabolic risks can be reduced. In the meanwhile, this project will develop strategies for improving muscle loss , muscle strength decline, and the quality life of the elderly.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03788577
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Loss
Currently open trials in the same condition.
- NCT06728722 — Ultrasound Detection of Body Composition in Critical Care · recruiting
- NCT06458530 — Examining the Effects of Vivo on Physical Function and Glycemic Level in Sedentary Older With Prediabetes. · NA · active not recruiting
- NCT06411964 — Galactooligosaccharide and Aging · NA · recruiting
- NCT06488872 — Comparison of Computed Tomography Data With Routine Measurements Concerning Bone and Muscle Health of Aged Individuals · recruiting
- NCT06136221 — Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease · NA · recruiting
Other National Yang Ming Chiao Tung University trials
Trials by the same sponsor.
- NCT07448857 — Kinematics and Muscle Activation of Scapula in Upper String Players With Neck Pain · recruiting
- NCT07318454 — Comparison of Abdominal Expansion and Abdominal Drawing-In Training With Manual and Verbal Cueing in Chronic Non-Specifi · NA · not yet recruiting
- NCT07494461 — Inhibitory Control and Gait Adaptability in Parkinson's Disease · not yet recruiting
- NCT07494487 — Reliability of Community Ambulation Ability, Fall Risk, and Dynamic Visual Acuity Assessments in Stroke · not yet recruiting
- NCT07494500 — Vestibular Training on Community Ambulation and Fall Risk in Stroke · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03788577 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Yang Ming Chiao Tung University
- Last refreshed: 14 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03788577.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing